Logo image
Chronic graft-versus-host disease and the risk of primary disease relapse: A meta-analysis
Journal article   Open access   Peer reviewed

Chronic graft-versus-host disease and the risk of primary disease relapse: A meta-analysis

Kittika Poonsombudlert, Jakarin Kewcharoen, Chanavuth Kanitsoraphan, Chattip Prueksapraopong and Nath Limpruttidham
Experimental hematology, Vol.74, pp.33-41
06/2019
DOI: 10.1016/j.exphem.2019.04.004
PMID: 31047963
url
https://doi.org/10.1016/j.exphem.2019.04.004View
Published (Version of record) Open Access

Abstract

Both primary disease relapse (PDR) and chronic graft-versus-host disease (cGVHD) have long been the dreaded outcomes for patients with hematologic malignancies. Previous theories have speculated an inverse relationship between the two; therefore, we attempted to verify the described association. We searched for titles of articles in MEDLINE (PubMed), Cochrane library, and EMBASE database that evaluated the association between PDR and cGVHD and conducted a random effect meta-analysis of 11 studies involving a total of 64,239 participants. We found a significantly decreased risk of developing PDR in patients with cGVHD, with a pooled risk ratio of 0.49 (95% confidence interval: 0.40-0.61, I  = 69.3%). We concluded that patients with cGVHD have a significantly lower risk of developing PDR compared with patients without cGVHD.
Chronic Disease Female Graft vs Host Disease - epidemiology Graft vs Host Disease - etiology Hematologic Neoplasms - epidemiology Hematologic Neoplasms - therapy Humans Male Recurrence Risk Factors

Details

Metrics

Logo image